Mycobacterium Infections:グローバル臨床試験レビューH1, 2013...市場調査レポートについてご紹介

【英文タイトル】Mycobacterium Infections Global Clinical Trials Review, H1, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Mycobacterium Infections 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Mycobacterium Infections 24
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Mycobacterium Infections Therapeutics Clinical Trials 31
Prominent Drug Comparison 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
Otsuka Pharmaceutical Co., Ltd. 37
Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 37
Tibotec BVBA 38
Clinical Trial Overview of Tibotec BVBA 38
Abbott Laboratories 39
Clinical Trial Overview of Abbott Laboratories 39
Janssen Infectious Diseases 40
Clinical Trial Overview of Janssen Infectious Diseases 40
Johnson & Johnson 41
Clinical Trial Overview of Johnson & Johnson 41
Epicentre Biotechnologies 42
Clinical Trial Overview of Epicentre Biotechnologies 42
Cadila Pharmaceuticals Ltd. 43
Clinical Trial Overview of Cadila Pharmaceuticals Ltd. 43
Vakzine Projekt Management GmbH 44
Clinical Trial Overview of Vakzine Projekt Management GmbH 44
AstraZeneca PLC 45
Clinical Trial Overview of AstraZeneca PLC 45
Sanofi 46
Clinical Trial Overview of Sanofi 46
Intercell AG 47
Clinical Trial Overview of Intercell AG 47
Sequella, Inc. 48
Clinical Trial Overview of Sequella, Inc. 48
Green Signal Bio Pharma Pvt. Ltd. 49
Clinical Trial Overview of Green Signal Bio Pharma Pvt. Ltd. 49
Alaeras, Inc 50
Clinical Trial Overview of Alaeras, Inc 50
Pharmacia GmbH 51
Clinical Trial Overview of Pharmacia GmbH 51
Lupin Limited 52
Clinical Trial Overview of Lupin Limited 52
UCB S.A. 53
Clinical Trial Overview of UCB S.A. 53
Insmed Incorporated 54
Clinical Trial Overview of Insmed Incorporated 54
Clinical Trial Overview of Top Universities / Institutes / Hospitals 55
University of Oxford 55
Clinical Trial Overview of University of Oxford 55
U.S. Centers for Disease Control and Prevention 57
Clinical Trial Overview of U.S. Centers for Disease Control and Prevention 57
University of Cape Town 59
Clinical Trial Overview of University of Cape Town 59
National Taiwan University Hospital 61
Clinical Trial Overview of National Taiwan University Hospital 61
London School of Hygiene & Tropical Medicine 62
Clinical Trial Overview of London School of Hygiene & Tropical Medicine 62
Statens Serum Institut 63
Clinical Trial Overview of Statens Serum Institut 63
Seoul National University Hospital 64
Clinical Trial Overview of Seoul National University Hospital 64
Johns Hopkins University 65
Clinical Trial Overview of Johns Hopkins University 65
University Medical Center Groningen 66
Clinical Trial Overview of University Medical Center Groningen 66
Tuberculosis Research Centre 67
Clinical Trial Overview of Tuberculosis Research Centre 67
Assistance Publique – Hopitaux de Paris 68
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 68
The University of Texas Health Science Center at Tyler 69
Clinical Trial Overview of The University of Texas Health Science Center at Tyler 69
Radboud University 70
Clinical Trial Overview of Radboud University 70
Harvard School of Public Health 71
Clinical Trial Overview of Harvard School of Public Health 71
Yonsei University 72
Clinical Trial Overview of Yonsei University 72
Makerere University 73
Clinical Trial Overview of Makerere University 73
Armed Forces Capital Hospital 74
Clinical Trial Overview of Armed Forces Capital Hospital 74
Taipei Medical University WanFang Hospital 75
Clinical Trial Overview of Taipei Medical University WanFang Hospital 75
Texas Tech University Health Sciences Center 76
Clinical Trial Overview of Texas Tech University Health Sciences Center 76
Karolinska Institutet 77
Clinical Trial Overview of Karolinska Institutet 77
Five Key Clinical Profiles 78
Appendix 102
Abbreviations 102
Definitions 102
Research Methodology 103
Secondary Research 103
About GlobalData 104
Contact Us 104
Disclaimer 104
Source 105


【レポート販売概要】

■ タイトル:Mycobacterium Infections:グローバル臨床試験レビューH1, 2013
■ 英文:Mycobacterium Infections Global Clinical Trials Review, H1, 2013
■ 発行日:2013年2月28日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160527
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。